• 23. Dezember 2024

Lead Pharma to Partner with Sanofi on Development of Treatments for Autoimmune Diseases

ByLead Pharma Holding BV

Feb 18, 2015
– RD collaboration and license agreement may yield potential first-in-class oral anti-ROR gamma (t) therapies
Teile den Beitrag mit Freunden

Kommentar verfassen